Form 4 for CTSO Cytosorbents Corp
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-05 · accession 0001104659-22-042913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-05 | 2022-04-05 | CTSO | Kim Jiny | Dir | A - Grant | $0.00 | +69.3K | 69.3K | New | $0 |
| D | 2022-04-05 | 2022-04-05 | CTSO | Kim Jiny | Dir | A - Grant | $0.00 | +17.2K | 17.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-05 | A | A | 69,300 | $0.00 | 69,300 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") that will be settled into shares of the Issuer's common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"). |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-04-05 | A | A | 17,250 | $0.00 | 17,250 | D | $3.09 · — to 2032-04-05 | 17,250 Common Stock | (F2) Reflects the grant of a stock option to purchase 17,250 shares of the Issuer's common stock, which will vest in four quarterly installments from the date of grant and becoming fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service on the applicable vesting date. |